| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |